Biomea Fusion Sets Sights on Key Diabetes and Obesity Milestones in 2026 Clinical Pipeline
Market Chameleon (Mon, 12-Jan 11:52 AM)
KOL Presentation Highlights Icovamenib’s Potential to Restore Beta Cell Function in Diabetes – A New Pathway for BMEA
Market Chameleon (Wed, 10-Dec 11:45 AM)
